![Image](http://www.msrc.co.uk/images/gallery/img_teri.jpg)
Efficacy and Safety of Teriflunomide in Patients With Relapsing Multiple Sclerosis and Treated With Interferon-beta (TERACLES).
Summary:Investigators in the United States and others around the world are recruiting 1455 people with relapsing multiple sclerosis for a study comparing two doses of oral teriflunomide(HMR1726), an investigational medication, or inactive placebo, in people taking any type of approved interferon beta. The study is sponsored by Sanofi-Aventis.... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/2933